# Avzivi

NDC: 82143-002
Generic name: bevacizumab-tnjn
Labeler / Manufacturer: Bio-Thera Solutions, Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250101

FDA application: BLA761198

## Active ingredients

- BEVACIZUMAB-TNJN: 400 mg/16mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82143-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82143-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a3976cf9-9edb-4ca2-9375-9bcd2e32f5b4